For our literature search, the keywords used were "Obeticholic acid," "Semaglutide," "Non-alcoholic fatty liver disease," "Liver Fibrosis," "GLP-1 agonist". Here, GLP1R is linked to metabolic dysfunction-associated steatotic liver disease.